Shopping Showdown: Walmart Takes On Amazon’s ‘Prime Day’
In case it wasn’t already perfectly obvious that Walmart is gunning for Amazon, the Bentonville, Ark. giant just kicked up its e-tailing competition.
Walmart announced today that it will also offer thousands of discounts for online purchases on July 15, the same day Amazon plans on hosting its Prime Day shopping extravaganza. And in its blog post announcing the sales, Walmart took a clear swipe at Amazon’s push to have shoppers subscribe to its $99 a year Prime service.
“We’ve heard some retailers are charging $100 to get access to a sale,” the Walmart blog says. “But the idea of asking customers to pay extra in order to save money just doesn’t add up for us. We’re standing up for our customers and everyone else who sees no rhyme or reason for paying a premium to save.”
Related: Amazon’s Prime Concern—A New Online Blitz by Walmart
Walmart, the world’s largest retailer, is also offering another limited-time deal to boost e-commerce sales. Starting today, customers will receive free standard shipping with online purchases that cost a minimum of $35, instead of the usual $50. The change will be effective for at least 30 days.
In February, Walmart CEO Doug McMillon told analysts on an earnings conference call that the company would invest between $1.2 billion and $1.5 billion in e-commerce throughout the year.
Neither Walmart nor Amazon has released information about specific sale offers yet, so the early hype might prove unwarranted, but the battle is clearly on and now the claws are out.
Update: Amazon responded to Walmart’s gibe with its own accusation. “We’ve heard some retailers are charging higher prices for items in their physical stores than they do for the same items online,” Greg Greeley, vice president of Amazon Prime, wrote in an email to Bloomberg. “The idea of charging your in-store customers more than your online customers doesn’t add up for us.”
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
